ValuEngine upgraded shares of Kewaunee Scientific (NASDAQ:KEQU) from a hold rating to a buy rating in a research report report published on Wednesday.

KEQU stock traded up $0.30 during midday trading on Wednesday, hitting $29.50. The stock had a trading volume of 518 shares, compared to its average volume of 4,325. The firm has a market cap of $79.50 million, a price-to-earnings ratio of 12.34 and a beta of 0.03. The company has a quick ratio of 1.71, a current ratio of 2.23 and a debt-to-equity ratio of 0.02. Kewaunee Scientific has a 1-year low of $25.10 and a 1-year high of $38.80.

Kewaunee Scientific (NASDAQ:KEQU) last released its earnings results on Tuesday, August 28th. The technology company reported $0.50 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.51 by ($0.01). The firm had revenue of $42.15 million during the quarter. Kewaunee Scientific had a net margin of 3.28% and a return on equity of 14.01%.

A number of institutional investors and hedge funds have recently bought and sold shares of KEQU. FMR LLC bought a new stake in Kewaunee Scientific in the second quarter valued at $401,000. Renaissance Technologies LLC increased its stake in Kewaunee Scientific by 5.2% in the second quarter. Renaissance Technologies LLC now owns 94,200 shares of the technology company’s stock valued at $3,386,000 after purchasing an additional 4,698 shares in the last quarter. North Star Investment Management Corp. increased its stake in Kewaunee Scientific by 2.4% in the third quarter. North Star Investment Management Corp. now owns 84,629 shares of the technology company’s stock valued at $2,666,000 after purchasing an additional 2,004 shares in the last quarter. O Shaughnessy Asset Management LLC increased its stake in Kewaunee Scientific by 72.5% in the third quarter. O Shaughnessy Asset Management LLC now owns 5,095 shares of the technology company’s stock valued at $160,000 after purchasing an additional 2,142 shares in the last quarter. Finally, BlackRock Inc. increased its stake in Kewaunee Scientific by 125.3% in the third quarter. BlackRock Inc. now owns 28,088 shares of the technology company’s stock valued at $885,000 after purchasing an additional 15,620 shares in the last quarter. 49.36% of the stock is owned by hedge funds and other institutional investors.

Kewaunee Scientific Company Profile

Kewaunee Scientific Corporation designs, manufactures, and installs laboratory, healthcare, and technical furniture products. The company operates in two segments, Domestic and International. Its products include steel, wood, laminate furniture, fume hoods, biological safety cabinets, laminar flow and ductless hoods, adaptable modular and column systems, moveable workstations and carts, epoxy resin worksurfaces, sinks, and accessories and related design services.

Recommended Story: Stock Symbol

To view ValuEngine’s full report, visit ValuEngine’s official website.

Receive News & Ratings for Kewaunee Scientific Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Kewaunee Scientific and related companies with MarketBeat.com's FREE daily email newsletter.